V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001816 | 240008732 | 1.2 | 104.1 | null | 2018-08-26 | 2018-08-26 | ALL UKALL2011 IndB Std Dex (PegAsp) | null | N | LENALIDOMIDE | 101132644 |
| 240001828 | 240008733 | 1.6 | 0 | null | 2021-11-13 | 2021-11-13 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | AML16 TRIAL | 100548346 |
| 240001877 | 240008734 | 0 | 36 | 03 | 2017-05-29 | 2017-05-29 | LIPOSOMAL DAUNORUBICIN + CYTARABINE (Vyxeos) | 02 | null | CNS HGG TEMOZOLOMIDE +XRT | 100172582 |
| 240001955 | 240008735 | 1.78 | 49.6 | Disease modification (D) | 2022-02-11 | 2022-02-23 | FLAIR trial | 02 | null | BUSULFAN | 101150207 |
| 240002007 | 240008736 | 1.06 | 91.2 | null | 2018-09-26 | 2018-10-02 | RUXOLITINIB | 02 | null | CYTARABINE + DAUNORUBICIN | 100038688 |
| 240002031 | 240008737 | 1.86 | 69.7 | Curative (C) | null | 2022-04-30 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | null | null | VENETOCLAX | 101860972 |
| 240002149 | 240008738 | 1.83 | 82 | null | 2019-01-23 | 2019-03-26 | Methotrexate intrathecal | Y | null | NOT MATCHED | 100262396 |
| 240002152 | 240008739 | 1.64 | 80.4 | null | 2019-03-01 | 2019-03-01 | null | 02 | N | CYTARABINE HIGH DOSE | 100343792 |
| 240002419 | 240008742 | 1.67 | 21.2 | null | 2019-02-19 | 2019-03-05 | DHAP - R | 02 | N | RUXOLITINIB | 101242152 |
| 240002740 | 240008744 | 1.73 | 64 | Curative (C) | 2020-01-27 | 2020-01-27 | Trial Unspecified | 02 | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 100530577 |
| 240002831 | 240008746 | 1.77 | 93.6 | null | 2017-01-20 | 2017-01-23 | null | 02 | null | BUSULFAN | 100005624 |
| 240000178 | 240008747 | 1.62 | 85.15 | null | 2018-09-09 | 2018-11-29 | Triple / Double Intrathecal Therapy + hydrocortisone | 02 | null | CYTARABINE + METHOTREXATE + RITUXIMAB | 101441540 |
| 240002149 | 240008754 | 1.54 | 83 | Not known (9) | 2021-04-28 | 2021-06-17 | GEMTUZUMAB OZOGAMICIN | 02 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 100262396 |
| 240002468 | 240008755 | 0 | 0 | null | 2020-01-26 | 2020-01-27 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | 02 | N | ABVD | 101132559 |
| 240000793 | 240008933 | null | null | null | null | 2017-10-24 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101264579 |
| 240000937 | 240008990 | null | null | Curative (C) | null | 2018-11-07 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100513296 |
| 240000943 | 240008993 | 1.65 | 95 | null | 2019-01-01 | 2019-01-01 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101368864 |
| 240000950 | 240008996 | null | null | null | null | 2019-09-23 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101742824 |
| 240000992 | 240009017 | null | null | null | null | 2016-09-12 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100068921 |
| 240000996 | 240009019 | null | null | null | null | 2019-01-31 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101352952 |
| 240000997 | 240009020 | null | null | null | null | 2019-03-16 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101737204 |
| 240001043 | 240009042 | null | null | Curative (C) | null | 2019-03-05 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100262699 |
| 240001047 | 240009045 | null | null | null | null | 2017-12-08 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101566637 |
| 240001114 | 240009071 | null | null | null | null | 2019-01-31 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101336567 |
| 240001121 | 240009073 | 1.71 | 60 | null | null | 2019-02-27 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100257376 |
| 240001140 | 240009079 | null | null | null | 2018-01-28 | 2018-01-29 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100771147 |
| 240001151 | 240009083 | null | null | null | null | 2015-02-14 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100460699 |
| 240001167 | 240009091 | null | null | null | null | 2016-06-24 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101752899 |
| 240001251 | 240009133 | null | null | null | null | 2017-10-24 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100935545 |
| 240001254 | 240009135 | null | null | Adjuvant (A) | null | 2019-08-06 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101550860 |
| 240001255 | 240009136 | null | null | null | null | 2017-12-15 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100575047 |
| 240001256 | 240009137 | null | null | null | null | 2016-03-24 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100189198 |
| 240001261 | 240009139 | null | null | Curative (C) | null | 2018-02-11 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101192668 |
| 240001263 | 240009141 | null | null | null | null | 2019-03-08 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100162072 |
| 240001264 | 240009142 | null | null | Curative (C) | null | 2017-04-16 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101864912 |
| 240001267 | 240009145 | 1.73 | 75 | null | null | 2016-07-13 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101063164 |
| 240001274 | 240009151 | null | null | null | null | 2018-11-12 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100221957 |
| 240001275 | 240009152 | null | null | Curative (C) | 2017-07-14 | 2017-11-17 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100557855 |
| 240001276 | 240009153 | null | null | null | null | 2019-04-15 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101172836 |
| 240001283 | 240009158 | null | null | null | null | 2017-07-05 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100741429 |
| 240001286 | 240009159 | null | null | null | 2016-06-25 | 2016-07-14 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101086092 |
| 240001301 | 240009169 | 1.65 | 75 | Curative (C) | null | 2017-07-18 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101465330 |
| 240001305 | 240009173 | 1.56 | 47.8 | 03 | null | 2019-05-18 | null | 02 | N | AML19 TRIAL | 101121583 |
| 240001306 | 240009174 | 1.65 | 92.35 | null | null | 2017-02-01 | null | 99 | N | METHOTREXATE | 101829082 |
| 240001309 | 240009176 | 1.78 | 0 | null | null | 2017-01-14 | null | null | null | TRIAL UNSPECIFIED | 101830435 |
| 240001310 | 240009177 | 1.68 | 51.5 | null | 2018-07-05 | 2018-08-28 | Rituximab | 02 | null | RITUXIMAB | 101573523 |
| 240001316 | 240009180 | 1.58 | 32.6 | 03 | 2020-08-24 | 2020-08-25 | AML 18 TRIAL | N | null | AML19 TRIAL | 101822694 |
| 240001319 | 240009182 | 1.65 | 93 | 03 | null | 2018-09-18 | null | N | N | TRIAL UNSPECIFIED | 101043596 |
| 240001324 | 240009185 | 1.71 | 85 | 03 | 2022-02-12 | 2022-03-03 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100378622 |
| 240001326 | 240009187 | 1.76 | 74 | null | null | 2019-12-13 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 101116854 |